Editas Medicine, Inc. (EDIT)

2.25 -0.13 (-5.46%) USD  |  NASDAQ  |  Jan 23, 12:23
More

Editas Medicine CAPEX To Revenue (TTM)

CAPEX To Revenue (TTM) Chart

View CAPEX To Revenue (TTM) for EDIT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View CAPEX To Revenue (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

CAPEX To Revenue (TTM) Range, Past 5 Years

View CAPEX To Revenue (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

CAPEX To Revenue (TTM) Benchmarks

View CAPEX To Revenue (TTM) Benchmarks
Start Trial
ADMA Biologics, Inc. Upgrade
Arcutis Biotherapeutics, Inc. Upgrade
Daré Bioscience, Inc. Upgrade
Cogent Biosciences, Inc. --
Janux Therapeutics, Inc. Upgrade